Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 clinical study, ...

Neuropathic pain affects more than 20 million people in the U.S., and at least a quarter of these cases are puzzling for ...

Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

Although systematic reviews have outlined the current treatment options for neuropathic pain, subsequent trials have necessitated an update of the NUMBER NEEDED TO TREAT (NNT) values presented in ...

The FDA has placed a trial of Rapport Therapeutics’ epilepsy drug for a type of nerve pain on hold while the biotech tweaks ...

Many types of medications, including over-the-counter (OTC) and prescription drugs, can help relieve joint pain due to ...

Arialief is a nutritional supplement skillfully produced to target the root cause of sciatic nerve discomfort. It comb ...

While conservative treatment can be done at home, it's important to see the vet before starting as there are other conditions that may mimic a pinched nerve such as other neurological disorders or ...

those with musculoskeletal conditions or nerve damage may require ongoing treatments to manage pain and maintain the ability ...

Pain-sensing neurons exchange signals with immune cells that drive endometriosis, sparking the pain associated with the condition, new research suggests.